EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us

ASCVD costs global health industry $680bn annually

Atherosclerotic cardiovascular disease costs global healthcare $680bn per year – the equivalent of Sweden’s entire economy, a new Office of Health Economics report has revealed.
Robot arm holding a cartoon heart

World Health Day: VML's top 10 healthcare trends

Healthcare is moving into a new phase in which trust, not just treatment, will shape success, says VML Health.
Eli Lilly office building

Lilly’s weight loss pill wins FDA approval

Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron.
World map with the Middle East highlight with a red glowing dot

Supply chains and trials hit by Middle East instability

Pharma companies are facing renewed pressure due to instability linked to the Middle East conflict.
Month in pharma news, explained

Month in pharma news, explained – March 2026

In this roundup, we take a look back at top moments from the pharmaceutical industry from March.
Fountain pen signing a contract

Promotion of biologics under fire from FDA

The recent FDA letters to four biologics companies signal a continued rise in enforcement activity.
Two people shaking hands

Lilly and Insilico strike historic $2.75bn AI alliance

The collaboration marks one of the largest generative AI-driven partnerships in the pharmaceutical industry to date.
A women sitting next to a doctor clutching her abdomen

Gesynta’s endometriosis candidate enters phase 2

The study moves the non-hormonal endometriosis candidate into mid-stage testing in a field ripe for new options.
We’ve noticed you’re accessing
from North/South America.